Deans' stroke musings: Sleep Apnea Treatment After Stroke (SATS) Trial: Is It Feasible?

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 4, 2019

Sleep Apnea Treatment After Stroke (SATS) Trial: Is It Feasible?

I couldn't sleep at all with a CPAP. I would suggest any of normobaric or nasal cannula options. But then I'm not medically trained so don't use me to suggest stuff to your doctor. Just cite the relevant research. Your doctor's knowledge of such research will tell you the competence level you are working with. When I cited research to my doctor he just totally dismissed it. I bet he hadn't read a single stroke research article in the 25 years since medical school. I moved doctors to get at the therapy in that research.

Normobaric oxygen (5)
nasal cannula (2)

Ronald D.ChervinMD, MS^†John D.KalbfleischPhD^‡Michael J.ZupancicMD^§Erin M.MigdaRN, BSN∗AnnaSvatikovaMD, PhD^¶MaryannConcannonMSW, RPSGT∗CoryMartinMA, RPSGT^‖Kevin J.WeatherwaxBS, CCRC, CCRA∗∗Lewis B.MorgensternMD∗

https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.06.010 Get rights and content

Sleep apnea affects more than half of patients with acute ischemic stroke and is associated with poor stroke outcome. This pilot study assessed the feasibility of a randomized, sham-controlled continuous positive airway pressure (CPAP) trial in subjects with acute ischemic stroke. Subjects identified with sleep apnea based on an apnea-hypopnea index ≥5 on overnight polysomnography or portable respiratory monitoring within 7 days of onset of stroke symptoms were randomized to receive active or sham CPAP for a 3-month period. Objective usage was ascertained by compliance data cards. Subjects, treating physicians, and outcome assessors were masked to intervention allocation. Among 87 subjects who provided consent, 74 were able to complete sleep apnea screening, 54 (73%) of whom had sleep apnea. Thirty-two subjects agreed to randomization. Of the 15 subjects who commenced active titration, 11 (73%) took the device home, and 8 (53%) completed the 3-month follow-up. Of the 17 subjects who commenced sham titration, 11 (65%) took the sham device home and completed the 3-month follow-up. The median cumulative usage hours over the 90 days were similar in the active group (53 hours; interquartile range, 22-173 hours) and the sham group (74 hours; interquartile range, 17-94 hours), and blinding to subject condition was successfully maintained. This first-ever randomized, sham-controlled trial of CPAP in patients with recent stroke and sleep apnea demonstrates that sham treatment can be an effective placebo.